According to REGENXBIO's latest financial reports the company's total debt is C$0.10 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | C$0.11 B | -0.6% |
2023-12-31 | C$0.11 B | -7.94% |
2022-12-31 | C$0.12 B | 16.45% |
2021-12-31 | C$0.11 B | 19.25% |
2020-12-31 | C$92.63 M | 527.97% |
2019-12-31 | C$14.75 M | 84.99% |
2018-12-31 | C$7.97 M | |
2017-12-31 | N/A | |
2014-12-31 | C$2.78 M | |
2013-12-31 | N/A |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | C$4.42 M | -95.98% | ๐บ๐ธ USA |